Details of the Drug

General Information of Drug (ID: DMVP183)

Drug Name
(+/-)-threo-N-(3-Phenylpropyl)ritalinol
Synonyms CHEMBL1254359; (+/-)-threo-N-(3-Phenylpropyl)ritalinol
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 323.5
Logarithm of the Partition Coefficient (xlogp) 4.6
Rotatable Bond Count (rotbonds) 7
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C22H29NO
IUPAC Name
(2R)-2-phenyl-2-[(2R)-1-(3-phenylpropyl)piperidin-2-yl]ethanol
Canonical SMILES
C1CCN([C@H](C1)[C@H](CO)C2=CC=CC=C2)CCCC3=CC=CC=C3
InChI
InChI=1S/C22H29NO/c24-18-21(20-13-5-2-6-14-20)22-15-7-8-16-23(22)17-9-12-19-10-3-1-4-11-19/h1-6,10-11,13-14,21-22,24H,7-9,12,15-18H2/t21-,22-/m1/s1
InChIKey
QQICWLNJJOCDRX-FGZHOGPDSA-N
Cross-matching ID
PubChem CID
52945256
TTD ID
D08XGL

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Dopamine transporter (DAT) TTVBI8W SC6A3_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Dopamine transporter (DAT) DTT SLC6A3 1.08E-03 -3.08 -1.99
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Quantitative structure-activity relationship studies of threo-methylphenidate analogs. Bioorg Med Chem. 2010 Oct 15;18(20):7221-38.